WHO Drug Information - Volume 39, No. 3

Overview

The Third issue of volume 39 for 2025 includes:

• Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum)
• Cefiderocol powder for concentrate for solution for infusion (cefiderocoli pulvis pro concentrato pro solutione pro infusione)
• Gliclazide sustained-release tablets (gliclazidum compressi prolongati)
• Gliclazide (gliclazidum)
• 1.18 High performance thin-layer chromatography
• Determination of diethylene glycol and ethylene glycol in liquid preparations for oral use
• Draft revision of chapter 2.11: micro determination of water by the Karl Fischer method

Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) Classification:

• ATC/DDD Classification (Temporary)
• ATC/DDD Classification (Final)

Volume 39, issue 3 concludes with the International Nonproprietary Names (INN) List - Recommended INN List No. 94